Connexion
E-mail
Mot de passe
Afficher le mot de passe
Retenir
Mot de passe oublié ?
Devenir membre gratuitement
Inscription
Inscription
Devenir membre
Inscription gratuite
Devenir client
Découvrez nos services
Paramètres
Paramètres
Cotations dynamiques 
OFFON
  1. Accueil Zonebourse
  2. Actions
  3. France
  4. Euronext Paris
  5. Sanofi
  6. Actualités
  7. Autres langues
    SAN   FR0000120578

SANOFI

(SAN)
  Rapport
SynthèseCotationsGraphiquesActualitésNotationsAgendaSociétéFinancesConsensusRévisionsDérivésFondsCommunauté 
SynthèseToute l'actualitéReco analystesAutres languesCommuniquésPublications officiellesActualités du secteurAnalyses Zonebourse
Actualités dans d'autres langues sur SANOFI
21/10Health Care Stocks Edging Higher At Close
21/10KADMON : Announces Expiration of HSR Waiting Period in Sanofi Deal
21/10GLOBAL MARKETS LIVE : Tesla, Unilever, Paypal, Elliott, Novartis...
21/10BEURSAGENDA : buitenlandse fondsen
21/10REGENERON PHARMACEUTICALS : Fda expands approval of dupixent (dupilumab) to include childr..
21/10PRESS RELEASE : Pfizer and BioNTech Announce Phase -3-
21/10GlobeNewswire/Daten aus Phase-3-Studie von Pfizer -4-
21/10SANOFI : Regeneron Win Expanded US FDA Nod for Asthma Drug Dupixent
20/10REGENERON PHARMACEUTICALS : Sanofi Say FDA Has Expanded Approval of Dupixent to Include Ch..
20/10SANOFI : says its flu vaccine can be co-administered with Moderna's COVID-19 shot
20/10Sanofi in cdc presentation says study results demonstrate that its flu vaccine & modern..
20/10Cigna's pharmacy benefit unit to prefer cheaper insulin drug from Viatris
15/10SANOFI : New long-term data reinforcing promising safety and efficacy profile of brain-pen..
15/10Sanofi Announces New Long-Term Data Reinforcing Promising Safety and Efficacy Profile o..
15/10GLOW LIFETECH CORP. : Glow Lifetech stärkt sein Geschäftsführungsteam mit führenden Persön..
14/10EFFECTEN-SPIEGEL AG : Net Asset Value zum 30.09.2021
14/10LVMH, SAP y BlackRock hicieron el trabajo
13/10SANOFI : Update from Sanofi regarding Kevzara (sarilumab) - Supply constraints anticipated..
13/10SANOFI : Says Multiple Sclerosis Drug Well-Tolerated at One-Year Mark of Phase 2b Extensio..
13/10SANOFI : Multiple Sclerosis Drug Remains Tolerable After One Year In Extension Study
13/10SANOFI : New long-term data reinforcing promising safety and efficacy profile of brain-pen..
13/10SANOFI : Expects Rheumatoid Arthritis Drug Supply To Remain Constrained Until 2022
13/10NHTHERAGUIX : NH TherAguix reporte son projet d'introduction en bourse sur le marché Euron..
12/10SANOFI : Warns of Kevzara Supply Constraints Until Early 2022
12/10UPDATE FROM SANOFI REGARDING KEVZARA : Supply constraints anticipated until early 2022
08/10SANOFI : - Positive results from the first study of high-dose influenza vaccine with a COV..
07/10MIRATI THERAPEUTICS : to Partner With Sanofi on Adagrasib-SAR442720 Combo Lung Cancer Tria..
07/10Mirati Therapeutics, Inc. Announces Non-Exclusive Clinical Collaboration Agreement with..
07/10SANOFI : New, late-breaking data at EADV highlights emerging clinical profile of amlitelim..
07/10SANOFI : annuncia risultati positivi studio su vaccino influenza con richiamo Covid
07/10SANOFI : Flu Jab With COVID-19 mRNA Booster Shows Immune Response, Safety In Trial
07/10SANOFI : says good results from flu vaccine with mRNA booster study
07/10SANOFI : Positive results from the first study of high-dose influenza vaccine with a COVID..
06/10DENALI THERAPEUTICS : Reports Phase 1 Results For Studies Targeting Amyotrophic Lateral Sc..
05/10Amgen's 'Underappreciated' Inflammation Portfolio Set to Trigger Growth, RBC Capital An..
04/10PRESS RELEASE : Pfizer and BioNTech Receive CHMP -2-
04/10GlobeNewswire/Pfizer und BioNTech erhalten -3-
04/10SANOFI : Enthera Pharmaceuticals Enthera Pharmaceuticals appoints Antonio Speziale as Chie..
01/10SANOFI : - New, late-breaking data at EADV highlights emerging clinical profile of amlitel..
01/10PRESS RELEASE : BioNTech to Present New Clinical and Preclinical Data Across Multiple Immu..
01/10GlobeNewswire/BioNTech präsentiert neue klinische und präklinische Daten aus mehreren I..
01/10BEXIMCO PHARMACEUTICALS : Wraps Up Majority Stake Acquisition In Sanofi Bangladesh
01/10GLOBENEWSWIRE/BIONTECH ERWEITERT KLI : Erster Patient in Phase 2-Studie mit individualisie..
01/10PRESS RELEASE : BioNTech Expands Clinical Oncology Portfolio with First Patient Dosed in P..
01/10Beximco Pharmaceuticals Limited acquired 54.6% in Sanofi Bangladesh Limited from Sanofi..
30/09SANOFI : Amlitelimab Antibody Shows Improvements In Dermatitis Symptoms
30/09SANOFI : New, late-breaking data at EADV highlights emerging clinical profile of amlitelim..
30/09Sanofi Announces New, Late-Breaking Data at EADV Highlights Emerging Clinical Profile o..
30/09SANOFI : announces positive Phase 1/2 study interim results for its first mRNA-based vacci..
30/09SANOFI INDIA : Completes Sale of Nutraceuticals Business
29/09GLOBAL MARKETS LIVE : Sanofi, ASML, Apple, United Airlines, Netflix...
29/09New purchases in the Investor Europe portfolio
29/09Nuevas compras en la cartera Inversor Europa
29/09COVID : India punta a produrre vaccino a mRna entro fine anno
29/09MÄRKTE EUROPA/Erholungsbewegung nach massivem Abverkauf
29/09CORONA-BLOG/Bundesweite Corona-Inzidenz steigt leicht auf 61,0
28/09CORONA-BLOG/Zulassung für Pfizer/Biontech-Impfstoff für Kinder verzögert sich
28/09Health Care Slips Amid Defensive Bias - Health Care Roundup
28/09SANOFI : to focus its COVID-19 development efforts on the recombinant vaccine candidate
28/09CORONA-BLOG/Russland mit Höchstzahl an Corona-Toten binnen 24 Stunden
28/09GLOBAL MARKETS LIVE : Airbus, Merck, Geely, Toyota, Activision Blizzard...
28/09CORONA-BLOG/Japan kündigt Ende des Gesundheitsnotstands an
28/09SANOFI : - New research presented at IDWeek 2021 reinforces Sanofi :'s robust vaccines pip..
28/09CORONA-BLOG/SPAHN : 75 Prozent aller Erwachsenen vollständig geimpft
28/09SANOFI : drops plans for messenger RNA vaccine against virus
28/09CORONA-BLOG/Frankfurter Buchmesse mit 3G-Regel auf Messegelände
28/09EUROPEAN MIDDAY BRIEFING : Stocks Fall as Traders Eye Inflation
28/09NORTH AMERICAN MORNING BRIEFING : Stock Futures Slip as Bond Yields Hit Three-Month High
28/09Sanofi no desarrollará vacuna experimental de Covid-19 pese a resultado prometedor
28/09Regeneron Gets FDA Priority Review of Libtayo in Advanced Cervical Cancer
28/09CORONA-BLOG/LUFTHANSA : Starke Nachfrage nach USA-Flügen
28/09Sanofi stellt Entwicklung von mRNA-Impfstoff ein
28/09SANOFI : Abandons mRNA COVID-19 Jab To Focus On Flu, Other Diseases
28/09CORONA-BLOG/Sanofi stellt Entwicklung von mRNA-Impfstoff ein
28/09GLAXOSMITHKLINE : Sanofi verabschiedet sich von mRNA-Impfstoff gegen Covid-19
1  2  3  4  5  6  7  8  9  10Suiv.
Prochain événement sur SANOFI